Original ArticleEmbolization Therapy for Refractory Hemorrhage in Patients with Chronic Subdural Hematomas
Introduction
Chronic subdural hematoma (CSDH) is an increasing clinical occurrence in modern neurosurgical practice. Trephination and drainage are the gold standard for patients with space-occupying CSDHs. Treatment outcomes are good in most patients, but recollection of blood requiring reoperation sometimes occurs. In the reports on CSDHs treated by burr-hole surgery, 11%–28% of operative cases developed a recurrent hematoma.1, 2 Subdural drainage is the most widely accepted management for symptomatic recurrences; however, previous studies3, 4 have found that revision surgery was unsuccessful in some cases.
Furthermore, it is more difficult to treat patients with CSDHs in whom resolution cannot be achieved even after repeated craniostomy and irrigation procedures. This intractability is more commonly encountered in patients with coagulopathy, elderly patients with cerebral atrophy, and patients on antithrombotic drugs.5 Treatment for intractable CSDHs should concentrate on addressing the capillary feeders of hematomas that originate from the middle meningeal artery (MMA). However, only a few sporadic reports of achieving transarterial therapy for patients with recurrent CSDH have been published in the literature.6, 7 In this study, the MMA embolization method was applied to patients with uncontrolled hemorrhage in refractory CSDHs and the potential role of this strategy for preventing further recurrence of hematomas was examined.
Section snippets
Patient Selection
A review was carried out of 372 patients who were hospitalized for burr-hole surgery to evacuate newly diagnosed unilateral or bilateral CSDHs from January 2007 to December 2015. These patients received 1 or 2 burr-hole trephinations for subdural irrigation under general or local anesthesia. A silicon tube was pulled out when drainage became negligible. The recurrence of CSDHs was shown by the reappearance of neurologic manifestations and an increase in hematoma volume on computed tomography
Results
Demographic and clinical data are listed in Table 1. The embolization group was found to be associated with older age (P = 0.041) and antiplatelet medication (P = 0.038) but not with history of head trauma. On comparing the neurologic status on admission, no statistical difference was observed in either group. Hypertension, diabetes, and cerebral infarct were more frequently observed in the embolization group, but these factors did not reach statistical significance. Severe brain atrophy (P
Discussion
Managing CSDH is a straightforward process, but an unremitting hemorrhage is sometimes difficult to treat. This factor was shown in the present study because the cohort had underlying medical diseases that complicated the clinical course of CSDHs. Revision surgery for drainage and irrigation is the first-line treatment for recollected hematomas. However, a few surgeons have performed complex procedures, such as craniotomy and membranectomy, subdural shunt, reservoir placement, hollow screw
Conclusions
The perioperative application of MMA embolization can accelerate the brain re-expansion rate, lessen the incidence of recurrence, and contribute to excellent outcomes for surgical cases of CSDHs with refractory recurrent hemorrhages.
Acknowledgments
The author would like to thank Dr. Hyuckwon Chang for the cerebral angiography and interventional procedure.
References (31)
- et al.
The role of external drains and peritoneal conduits in the treatment of recurrent chronic subdural hematoma
World Neurosurg
(2010) - et al.
Various surgical treatments of chronic subdural hematoma and outcome in 172 patients: is membranectomy necessary?
Surg Neurol
(2004) - et al.
Subdural peritoneal shunt: treatment for bilateral chronic subdural hematoma
Surg Neurol
(1996) - et al.
Role of angiogenic growth factors and inflammatory cytokines on recurrence of subdural hematoma
Surg Neurol
(2009) - et al.
The outer neomembrane of chronic subdural hematoma
Neurosurg Clin N Am
(2000) - et al.
Anticoagulants and antiplatelet agents and the risk of development and recurrence of chronic subdural haematomas
J Clin Neurosci
(2009) - et al.
The relationship between brain surface elastance and brain reexpansion after evacuation of chronic subdural hematoma
Surg Neurol
(1996) - et al.
Outcomes and recurrence rates in chronic subdural haematoma
Br J Neurosurg
(2007) - et al.
Independent predictors for recurrence of chronic subdural hematoma
J Korean Neurosurg Soc
(2015) - et al.
Mini-craniotomy as the primary surgical intervention for the treatment of chronic subdural hematoma-a retrospective analysis
Acta Neurochir (Wien)
(2014)
Independent predictors for recurrence of chronic subdural hematoma: a review of 343 consecutive surgical cases
Neurosurgery
Middle meningeal artery embolization for refractory chronic subdural haematoma. Case report
J Neurosurg
Transarterial embolisation for refractory bilateral chronic subdural hematomas in a case with dentatorubral-pallidoluysian atrophy
Acta Neurochir (Wien)
Chronic subdural haematoma treated by craniotomy, durectomy, outer membranectomy and subgaleal suction drainage. Personal experience in 39 patients
Br J Neurosurg
The minimally invasive endoscopic management of septated chronic subdural hematomas: surgical technique
Acta Neurochir (Wien)
Cited by (103)
Middle Meningeal Artery Embolization for Subdural Hematoma: An Institutional Cohort and Propensity Score-Matched Comparison with Conventional Management
2023, Clinical Neurology and Neurosurgery
Conflict of interest statement: The authors declare that the article content was composed in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.